GS
GenSight Biologics S.A.
GSGTF · OTC
$0.09 +0.00% (+$0.00)
Market Cap 12.9M €
P/E Ratio -
Div. Yield -
ROE -
Analiză
Un raport AI despre afacere, finanțe, evaluare, sentiment, știri și riscuri - scris în câteva minute.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 12,902.00x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 92.71%
EPS growth N/A
FCF growth N/A
Profitability
22 /100
Weak Gross margin 100.10%
Net margin 1,204,350.00%
FCF margin 0.00%
Quality
57 /100
Average ROIC 1,518.79%
ROA 145.79%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.39x
Int. coverage -11.86x
Debt/Equity N/A
Stability
46 /100
Moderate Beta 0.70x
Rev. volatility 59.45%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre GSGTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Laurence Rodriguez
Employees
13
Headquarters
Paris
Evenimente viitoare
29 SEPT.
Earnings
Upcoming earnings report